[ATRI] Atrion Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 500.05 Change: 2.45 (0.49%)
Ext. hours: Change: 0 (0%)

chart ATRI

Refresh chart

Strongest Trends Summary For ATRI

ATRI is in the medium-term up 36% above S&P in 1 year. In the long-term up 3045% in 22 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products for medical applications primarily in the United States and Canada. The company?s fluid delivery products comprise luer syringe check valves and one-way valves; tubing clamps; and specialized intravenous sets for use in anesthesia and oncology applications. Its cardiovascular products include MPS2 Myocardial Protection System that delivers essential fluids and medications to the heart during open-heart surgery; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The company?s ophthalmic products comprise contact lens disinfection cases; and a line of ballo

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS16.48 EPS Growth - 4 Quarters10.05% EPS Growth - Q/Q35.26%
EPS Growth - Y/Y2.83% Sales Growth - 4 Quarters 9.42% Sales Growth - Q/Q17.22% P/E34.28
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA17.74% ROE20.25% ROI
Current Ratio9.73 Quick Ratio5.97 Long Term Debt/Equity Debt Ratio0.05
Gross Margin48.82% Operating Margin29.16% Net Profit Margin19.77% Dividend Payout Ratio-19.75%
Dividend Yield
Fundamental Data
Cash From Financing Activities-18.39 M Cash From Investing Activities5.74 M Cash From Operating Activities7.75 M Gross Profit18.52 M
Net Profit7.6 M Operating Profit11.49 M Total Assets158.99 M Total Current Assets69.19 M
Total Current Liabilities7.11 M Total Debt Total Liabilities19.69 M Total Revenue38.32 M
Technical Data
High 52 week806.44 Low 52 week525.75 Last close806.44 Last change1.13%
RSI72.05 Average true range12.98 Beta0.58 Volume8.48 K
Simple moving average 20 days2.91% Simple moving average 50 days6.91% Simple moving average 200 days19.09%
Performance Data
Performance Week1.61% Performance Month3.08% Performance Quart11.6% Performance Half25.63%
Performance Year38.63% Performance Year-to-date9% Volatility daily1.04% Volatility weekly2.32%
Volatility monthly4.75% Volatility yearly16.47% Relative Volume216.8% Average Volume9.83 K
New High New Low

News

2019-03-04 12:22:09 | Is Atrion Corporation’s NASDAQ:ATRI Balance Sheet A Threat To Its Future?

2019-02-26 16:30:00 | Atrion Reports Results for Fourth Quarter and Full Year 2018

2019-02-26 14:17:24 | Atrion Corporation Declares Quarterly Cash Dividend

2019-02-21 08:00:00 | Investor Expectations to Drive Momentum within International Business Machines, Trex, ForeScout Technologies, Red Hat, Amedisys, and Atrion — Discovering Underlying Factors of Influence

2019-02-06 11:20:11 | Have Insiders Been Selling Atrion Corporation NASDAQ:ATRI Shares?

2019-01-11 10:47:40 | Should You Like Atrion Corporation’s NASDAQ:ATRI High Return On Capital Employed?

2018-12-10 12:37:32 | Does Atrion Corporation’s NASDAQ:ATRI CEO Pay Compare Well With Peers?

2018-11-12 13:22:31 | Atrion Corporation Declares Quarterly Cash Dividend

2018-11-09 16:34:28 | Atrion: 3Q Earnings Snapshot

2018-11-09 16:30:00 | Atrion Reports Third Quarter Results

2018-11-09 13:30:47 | Do Insiders Own Lots Of Shares In Atrion Corporation NASDAQ:ATRI?

2018-10-19 08:20:00 | Research Report Identifies Loxo Oncology, Atrion, Alexander's, Broadridge Financial Solutions, International Flavors & Fragrances, and Conagra Brands with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-10-10 14:27:20 | Does Atrion Corporation’s NASDAQ:ATRI PE Ratio Warrant A Buy?

2018-09-04 14:16:43 | Can Atrion Corporation’s NASDAQ:ATRI ROE Continue To Surpass The Industry Average?

2018-08-14 16:30:00 | Atrion Corporation Increases Quarterly Cash Dividend by 13%

2018-08-07 17:00:50 | Atrion: 2Q Earnings Snapshot

2018-08-07 16:45:00 | Atrion Reports Second Quarter Results

2018-05-31 07:10:00 | Blog Exposure - FDA Approved Expanded Indications for TransEnterix's Senhance Surgical System

2018-05-24 08:25:00 | New Research: Key Drivers of Growth for CSW Industrials, Cavco Industries, Intra-Cellular Therapies, Atrion, QAD, and A V Homes — Factors of Influence, Major Initiatives and Sustained Production

2018-05-22 15:05:12 | Atrion Corporation Declares Quarterly Cash Dividend

2018-05-10 05:12:13 | Atrion: 1Q Earnings Snapshot

2018-05-09 16:30:00 | Atrion Reports First Quarter Results

2018-05-08 10:59:15 | Where Atrion Corporation NASDAQ:ATRI Stands In Terms Of Earnings Growth Against Its Industry

2018-04-03 08:00:00 | Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals — Discovering Underlying Factors of Influence

2018-03-12 08:00:00 | Free Post Earnings Research Report: Mettler-Toledo’s Quarterly Earnings Increased 13.07%

2018-03-10 09:14:26 | Atrion Corporation NASDAQ:ATRI Delivered A Better ROE Than The Industry, Here’s Why

2018-02-28 05:03:10 | Atrion posts 4Q profit

2018-02-27 16:30:00 | Atrion Reports 2017 Results for Fourth Quarter and Full Year

2018-02-27 14:31:37 | Atrion Corporation Declares Quarterly Cash Dividend

2018-02-21 11:58:22 | Should You Be Tempted To Buy Atrion Corporation NASDAQ:ATRI Because Of Its PE Ratio?

2018-02-01 08:00:00 | Market Trends Toward New Normal in Alexander's, Atrion, FS, Gilead Sciences, Abbott Laboratories, and Johnson & Johnson — Emerging Consolidated Expectations, Analyst Ratings

2017-12-18 14:38:32 | ETFs with exposure to Atrion Corp. : December 18, 2017

2017-12-05 08:36:37 | Atrion Corp. :ATRI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017

2017-12-01 10:26:09 | ETFs with exposure to Atrion Corp. : December 1, 2017

2017-12-01 09:51:04 | Atrion Corp. : ATRI-US: Dividend Analysis : December 01st, 2017 record date : By the numbers : December 1, 2017

2017-11-27 07:32:51 | Atrion Corp. breached its 50 day moving average in a Bullish Manner : ATRI-US : November 27, 2017

2017-11-26 06:05:05 | Does Atrion Corporation’s ATRI 18.4% Earnings Growth Make It An Outperformer?

2017-11-08 18:51:51 | Atrion posts 3Q profit

2017-11-08 16:30:00 | Atrion Reports Third Quarter Results

2017-11-08 12:41:17 | Atrion Corporation Declares Quarterly Cash Dividend

2017-11-07 09:41:30 | ETFs with exposure to Atrion Corp. : November 7, 2017

2017-11-06 07:16:56 | Atrion Corp. breached its 50 day moving average in a Bullish Manner : ATRI-US : November 6, 2017

2017-11-01 11:05:15 | Should You Be Tempted To Buy Atrion Corporation ATRI At Its Current Price?

2017-10-26 11:01:43 | Atrion Corp. – Value Analysis NASDAQ:ATRI : October 26, 2017

2017-10-25 08:15:35 | Atrion Corp. breached its 50 day moving average in a Bearish Manner : ATRI-US : October 25, 2017

2017-10-04 09:57:55 | Atrion Corp. : ATRI-US: Dividend Analysis : September 15th, 2017 record date : By the numbers : October 4, 2017

2017-10-02 10:41:24 | ETFs with exposure to Atrion Corp. : October 2, 2017

2017-09-13 17:22:29 | ETFs with exposure to Atrion Corp. : September 13, 2017

2017-09-08 17:01:50 | Atrion Corp. :ATRI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 8, 2017

2017-08-28 20:01:45 | Atrion Corp. – Value Analysis NASDAQ:ATRI : August 29, 2017